XML 24 R25.htm IDEA: XBRL DOCUMENT
v3.3.0.814

Fair Value (Tables) | 9 Months Ended
--- | ---
Sep. 26, 2015
Fair Value Disclosures [Abstract] |
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis | Assets, liabilities, and noncontrolling interest measured at fair value on a recurring basis are summarized below:
| September 26, 2015
| Level 1 |  | Level 2 |  | Level 3 |  | Total
| (in thousands)
Cash equivalents | $ | — |  |  | $ | 159 |  |  | $ | — |  |  | $ | 159 |
Other current assets: |  |  |  |  |  |  |
Marketable securities | 4,570 |  |  | — |  |  | — |  |  | 4,570 |
Foreign currency forward contracts | — |  |  | 16 |  |  | — |  |  | 16 |
Other assets: |  |  |  |  |  |  |
Life insurance policies | — |  |  | 19,346 |  |  | — |  |  | 19,346 |
Total assets measured at fair value | $ | 4,570 |  |  | $ | 19,521 |  |  | $ | — |  |  | $ | 24,091 |
Other current liabilities: |  |  |  |  |  |  |
Contingent consideration | $ | — |  |  | $ | — |  |  | $ | 1,111 |  |  | $ | 1,111 |
Foreign currency forward contracts | — |  |  | 306 |  |  | — |  |  | 306 |
Other long-term liabilities: |  |  |  |  |  |  |
Contingent consideration | — |  |  | — |  |  | 169 |  |  | 169 |
Redeemable noncontrolling interest | — |  |  | — |  |  | 27,447 |  |  | 27,447 |
Total liabilities and redeemable noncontrolling interest measured at fair value | $ | — |  |  | $ | 306 |  |  | $ | 28,727 |  |  | $ | 29,033 |
| December 27, 2014
| Level 1 |  | Level 2 |  | Level 3 |  | Total
| (in thousands)
Cash equivalents | $ | — |  |  | $ | 1,934 |  |  | $ | — |  |  | $ | 1,934 |
Other assets: |  |  |  |  |  |  |
Life insurance policies | — |  |  | 20,520 |  |  | — |  |  | 20,520 |
Total assets measured at fair value | $ | — |  |  | $ | 22,454 |  |  | $ | — |  |  | $ | 22,454 |
Other current liabilities: |  |  |  |  |  |  |
Contingent consideration | $ | — |  |  | $ | — |  |  | $ | 1,583 |  |  | $ | 1,583 |
Other long-term liabilities: |  |  |  |  |  |  |
Contingent consideration | — |  |  | — |  |  | 1,245 |  |  | 1,245 |
Redeemable noncontrolling interest | — |  |  | — |  |  | 28,419 |  |  | 28,419 |
Total liabilities and redeemable noncontrolling interest measured at fair value | $ | — |  |  | $ | — |  |  | $ | 31,247 |  |  | $ | 31,247 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following table provides a rollforward of the fair value of the Company’s redeemable noncontrolling interest:
| Nine Months Ended
| September 26, 2015 |  | September 27, 2014
| (in thousands)
Beginning balance | $ | 28,419 |  |  | $ | 20,581 |
Additions | — |  |  | — |
Total gains or losses (realized/unrealized): |  |  |
Net income attributable to noncontrolling interest | 614 |  |  | 523 |
Foreign currency translation | (693 | ) |  | (113 | )
Change in fair value, included in additional paid-in capital | (893 | ) |  | 3,559 |
Ending balance | $ | 27,447 |  |  | $ | 24,550 |
Fair Value, Contingent Consideration | The following table provides a rollforward of the contingent consideration related to the acquisitions of Argenta, BioFocus, VivoPath and ChanTest. See Note 2, “Business Acquisitions.”
| Nine Months Ended
| September 26, 2015 |  | September 27, 2014
| (in thousands)
Beginning balance | $ | 2,828 |  |  | $ | — |
Additions | 675 |  |  | 2,428 |
Payments | (600 | ) |  | — |
Total gains or losses (realized/unrealized): |  |  |
Reversal of previously recorded contingent liability and change in fair value | (1,623 | ) |  | 120 |
Ending balance | $ | 1,280 |  |  | $ | 2,548 |

X
- Definition [Table Text Block] for Fair Value, Contingent Consideration [Table] + References No definition available. + Details
Name: | crl_FairValueContingentConsiderationTableTextBlock
Namespace Prefix: | crl_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair Value, Redeemable Noncontrolling Interest [Table Text Block] + References No definition available. + Details
Name: | crl_FairValueRedeemableNoncontrollingInterestTableTextBlock
Namespace Prefix: | crl_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration